Mark Dean-Netscher has been appointed chief operating officer of Penn Pharma, effective May 16th. Mr. Dean-Netscher will be responsible for overseeing operation of the company’s specials and global contract manufacturing and development services, including analytical services, formulation, clinical trial supplies, logistics and commercial manufacturing and packaging.

Mr. Dean-Netscher has more than 20 years of experience in the pharmaceutical manufacturing industry. He has held senior positions including heading up Reckitt Benckiser’s global healthcare operation and most recently, overseeing a significant portion of Catalent’s global production facilities as operations vice president International and Europe.

Penn’s chief executive officer, Richard Yarwood, said, “We are delighted to welcome Mark on board. I am confident that he will be able to work competently as part of our senior management team to further strengthen the business’s market presence and to ensure that Penn Pharma remains a well-known and well-respected name worldwide.”